NCT05185531 2024-01-05
Notable-HCC
Shandong Cancer Hospital and Institute
Phase 1 Unknown
Clinical Trials
15 trialsNCT06040177 2023-09-15
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Phase 1/2 Unknown
NCT04387695 2023-02-16
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
First Affiliated Hospital of Zhejiang University
Phase 3 Unknown
NCT02921139 2021-08-30
TASABR
Dalin Tzu Chi General Hospital
Phase NA Unknown
NCT04913480 2021-06-04
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
The University of Hong Kong
Phase 2 Unknown
NCT04167293 2021-03-23
ISBRT01
Sun Yat-sen University
Phase 2/3 Unknown
NCT03898921 2020-11-24
RFA vs. SBRT for Small HCC
Sun Yat-sen University
Phase 3 Unknown
NCT04434989 2020-06-17
SAIL
Sun Yat-sen University
Phase NA Unknown
NCT04202523 2019-12-17
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT04169399 2019-11-19
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT
Sun Yat-sen University
Phase 2 Unknown
NCT01825824 2019-09-20
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
Korea Cancer Center Hospital
Phase 2 Unknown
NCT03609151 2018-08-01
Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown
NCT03609268 2018-08-01
Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown
NCT03326375 2017-10-31
STH
Gangneung Asan Hospital
Phase NA Unknown
NCT00691691 2012-01-19
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
AHS Cancer Control Alberta
Phase 2 Unknown